Viridium Pacific Group (CVE:VIR) Stock Price Up 5.6% – Should You Buy?

Shares of Viridium Pacific Group Ltd (CVE:VIRGet Free Report) were up 5.6% on Monday . The company traded as high as C$0.41 and last traded at C$0.38. Approximately 26,500 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 92,632 shares. The stock had previously closed at C$0.36.

Viridium Pacific Group Stock Performance

The stock has a 50 day moving average of C$0.38 and a two-hundred day moving average of C$0.38. The firm has a market capitalization of C$37.52 million and a P/E ratio of -2.97.

About Viridium Pacific Group

(Get Free Report)

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use.

See Also

Receive News & Ratings for Viridium Pacific Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viridium Pacific Group and related companies with MarketBeat.com's FREE daily email newsletter.